Skip to Content

Join the 'Flibanserin' group to help and get support from people like you.

Flibanserin News

'Female Viagra' May Lift a Younger Woman's Libido

Posted 14 May 2017 by Drugs.com

SUNDAY, May 14, 2017 – If a woman's sex drive has waned to the point where she's distressed about it, or the issue is causing relationship problems, the medication dubbed "female Viagra" may help, a review of several studies suggests. First approved by the U.S. Food and Drug Administration in 2015, the drug flibanserin (Addyi) may improve sexual desire, arousal, lubrication, orgasm, satisfaction ...

'Female Libido' Pill May Not Be Worth It: Researchers

Posted 29 Feb 2016 by Drugs.com

MONDAY, Feb. 29, 2016 – The much-touted "female libido" pill seems to cause a host of serious side effects while failing to spark much additional passion in a woman's life, a new review suggests. Addyi (flibanserin) quadruples the risk of dizziness and sleepiness, more than doubles the chances of nausea, and increases the risk of fatigue by more than half, according to the analysis. For all that ...

Pill for Low Libido in Women Goes on Sale on Saturday

Posted 16 Oct 2015 by Drugs.com

FRIDAY, Oct. 16, 2015 – The so-called "little pink pill" – the controversial drug intended to boost flagging sex drive in women – goes on sale on Saturday. Flibanserin (Addyi) is the first U.S. Food and Drug Administration-approved drug designed to help women with low libido. But that approval, announced in August, came with significant restrictions because the drug can cause severely low ...

FDA Approves Addyi (flibanserin) for Hypoactive Sexual Desire Disorder in Premenopausal Women

Posted 19 Aug 2015 by Drugs.com

August 18, 2015 - The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to Addyi’s approval, there were no FDA-approved treatments for sexual desire disorders in men or women. “Today’s approval provides women distressed by their low sexual desire with an approved treatment opti ...

Addyi Female Libido Pill Now FDA Approved

Posted 19 Aug 2015 by Drugs.com

WEDNESDAY, Aug. 19, 2015 – Addyi (flibanserin) has been approved by the U.S. Food and Drug Administration as the first drug to treat low sexual desire among premenopausal women. The drug is for women who do not have an underlying physical or psychological cause for the disorder, the agency said in a news release. Addyi's label will warn that it can cause blood pressure to drop severely and may ...

Ask a Question

Further Information

Related Condition Support Groups

Hypoactive Sexual Desire Disorder

Related Drug Support Groups

Addyi

Flibanserin Patient Information at Drugs.com